Pure Global

HbA1c Control - India CDSCO Medical Device Registration

HbA1c Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000055_29ad24a3e57465047ef8acf56cd969aa_1fdb39c2aeb3a03deabe2c761a53a5f9. This device is marketed under the brand name Lifotronic. The license holder is ARANAX MEDICAL PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c Control
UID: IMP/IVD/2023/000055_29ad24a3e57465047ef8acf56cd969aa_1fdb39c2aeb3a03deabe2c761a53a5f9

Brand Name

Lifotronic

Device Class

Class B

Approving Authority

CDSCO

Product Information

The HbA1c Control is intended for quality control of glycated hemoglobin (Lifotronic) assay on the hemoglobin analyzer

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing